ATTRIBUTE_CM Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Cardiomyopathy. Prot#AG10-301

Project: Research project

Project Details

StatusActive
Effective start/end date4/18/194/18/22

Funding

  • PRA Health Sciences (Prot#AG10-301)
  • Eidos Therapeutics, Inc. (Prot#AG10-301)